Aussie swimmer's close brush with death after stingray narrowly misses her artery in rare attack
A volunteer marine researcher has narrowly escaped with her life after an stingray barb missed her artery in a rare attack.
Pam Bennett, 68, was part of a team recently snorkelling 50metres offshore at Treasure Cove on South Australia 's Southern Yorke Peninsula.
Ms Bennett, a local, had been studying the effects of an algae bloom on the water's wildlife and the unusual number of fish found dead along the coastline.
She noticed she was above an eagle ray and even though she 'quickly swam out of the way', a 16cm-long barb pierced her arm.
'I actually didn't see that stingray - he had come from behind, I think. He had actually attacked,' she told the ABC.
'That's not their normal behaviour.'
A second eagle ray attempted to lash out at another member of the group, Dr Mike Bossley, but it missed its target.
Ms Bennett recalled feeling as though she'd been attacked by a dog as her teammates floated her to shore.
'I kind of expected them to take the wetsuit off and see teeth marks,' she said.
The 68-year-old managed to scale a cliff back to the roadside and she was taken to Yorketown Hospital for an x-ray.
Doctors discovered the full barb had been lodged in Ms Bennett's arm, missing her brachial artery.
A severed brachial artery can cause a person to fall unconscious is just 15 seconds and death in 90 seconds.
Both she and Dr Bossley believe the unusually aggressive stingrays attacked them due to the ongoing algae bloom.
In the past two months several sharks, stingrays, octopuses and fish have washed onto South Australian beaches.
It's believed the spike in deaths has been caused by the algae sticking to the marine life and limiting their oxygen intake.
Ms Bennett was later flown to Adelaide to undergo surgery to remove the large barb.
She told Nine News on Tuesday she is recovering well.
'I've got a sore arm, that's all,' she said.
Dr Bossley warned that while the attack was uncharacteristic of stingrays, similar incidents could occur if the algae continues to spread.
'The only thing that will help is if we get a decent storm coming in from the south-west, which will break up the bloom and disperse it,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
12 minutes ago
- BBC News
How dem make anti-venom from man wey snake bite 200 times
Di blood of one US man wey deliberately inject imsef wit snake venom for nearly twenty years don lead to "unparalleled" anti-venom, scientists tok. Antibodies find in Tim Friede blood don shown to protect against deadly doses from one wide range of species in animal tests. Current therapies gatz match di specific species of venomous snake wey bite anyone. But Oga Friede 18-year mission fit lead to ogbonge step of finding universal anti-venom against all snakebites - wey dey kill up to 140,000 pipo evri year and leave three times as many needing amputations or facing permanent disability. In total, Mr Friede don endure more dan 200 bites and more dan 700 injections of venom e prepare from some of di world deadliest snakes, including multiple species of mambas, cobras, taipans and kraits. E bin want build up im immunity to protect imsef wen e dey handle snakes, documenting im exploits on YouTube. But di former truck mechanic tok say e don "completely screw up" early on wen two cobra bites wey happun in quick succession leave am in coma. "I no wan die. I no wan lose one finger. I no wan miss work," e tell BBC. Oga Friede motivation na to develop beta therapies for di rest of di world, explaining: "E just become lifestyle and I just keep pushing and pushing and pushing as hard as I fit push - for di pipo wey dey 8,000 miles away from me wey don die from snakebite". 'I go love to get my hands on some of your blood' Currently dem dey make anti-venom by injecting small doses of snake venom into animals, such as horses. Dia immune system dey fight di venom by producing antibodies and dem go harvest am to use as therapy. But venom and anti-venom gatz dey closely matched becos di toxins for venomous bite no be di same from one species to anoda. Dem even get wide variety within di same species – anti-venom wey dem make from snakes from India dey less effective against di same species for Sri Lanka. One team of researchers begin dey search for one type of immune defence wey dem dey call broadly neutralising antibodies. Instead of targeting di part of toxin wey make am unique, dem dey target di part wey make am common to entire classes of toxin. Dat na wen Dr Jacob Glanville, chief executive of biotech company Centivax, come across Tim Friede. "Immediately I look say 'if anybody in di world don develop dis broadly neutralising antibodies, e go be am' and so I reach out," e tok. "Di first call, I be like 'dis fit dey awkward, but I go love get my hands on some of your blood'." Oga Friede agree and di work dey ethically approved becos di study go only take blood, rather dan give am more venom. Di research focus on elapids – one of di two families of venomous snakes – such as coral snakes, mambas, cobras, taipans and kraits. Elapids primarily use neurotoxins in dia venom, wey dey paralyse dia victim and e dey fatal wen dem stop di muscles e need to breathe. Researchers don pick 19 elapids identify by di World Health Organization as being among di deadliest snakes on di planet. Dem don begin to source for Oga Friede blood for protective defences. Dia work, dey detailed in di journal Cell, identify two broadly neutralising antibodies wey fit target two classes of neurotoxin. For experiments on mice, di cocktail mean say di animals bin survive deadly doses from 13 of di 19 species of venomous snake. Dem bin get partial protection against di remaining six. Dis na "unparalleled" breadth of protection, according to Dr Glanville, wey say e "likely cover a whole bunch of elapids for wey no get current anti-venom". Di team dey try to refine di antibodies further and see if adding fourth component fit lead to total protection against elapid snake venom. Di oda class of snake – di vipers – dey rely more on haemotoxins, wey dey attack di blood, rather dan neurotoxins. In total around one dozen broad classes of toxin in snake venom, wey also include cytotoxins dey directly kill cells. "I think in di next 10 or 15 years we go get somtin effective against each one of dis toxin classes," Prof Peter Kwong, one of di researchers for Columbia University, tok. And di hunt continue inside Oga Friede blood samples. "Tim antibodies dey really quite extraordinary - e bin teach im immune system to get dis veri, veri broad recognition," Prof Kwong tok. Di ultimate hope na to get either single anti-venom wey fit do evritin, or one injection for elapids and one for vipers. Prof Nick Casewell, na di head of di centre for snakebite research and interventions for di Liverpool School of Tropical Medicine - e tok say di breadth of protection report bin dey unusual and provide "strong piece of evidence" wey get feasible approach. "No doubt say dis work move di field forward in exciting direction." But e caution say "plenti work still dey to do" and di anti-venom still go need extensive testing bifor dem fit use am in pipo. But for Oga Friede, reaching dis stage "make me feel good". "I dey do somtin good for humanity and e bin dey veri important to me. I dey proud of am. E dey pretty cool."
Daily Mail
3 hours ago
- Daily Mail
Tragic update after young girl, 7, captured hearts across Australia with her brave cancer battle - and the heartbreaking four words she told her parents
A young girl who captivated the hearts of Australians during her cancer battle has died years later after relapsing. Uma Tomarchio was two years old when she was diagnosed with Acute Lymphoblastic Leukaemia in 2020, before it worsened to a more aggressive form of cancer, Acute Myeloid Leukaemia, in 2022. When her Italian parents, Giuseppe Tomarchio and Lucia Gardini, were unable to secure Medicare assistance for the then-four-year-old's treatments, they reached out to the media and public for help, with Aussies donating more than $300,000. In September that year, a successful bone marrow transplant meant she was largely cancer-free, until she was diagnosed again with Epstein-Barr Virus – potentially passed through donor cells – and then later with Lymphoma. After a gut-wrenching stint in intensive care and an induced coma, Uma began to regain her strength by February 2023 as a five-year-old. But in June this year, family friend Megan Mahon announced the young girl had died at seven-years-old. She had relapsed with therapy-related Acute Myeloid Leukaemia in May, and while undergoing chemotherapy, Uma developed a fast-moving lung infection which her immune system was too weak to fight. Ms Mahon said the fundraising and tireless work of her doctors had given Uma two fun-filled years of life before she relapsed with cancer for the fourth time. She revealed the heartbreaking message Uma gave her parents in her final days, saying she 'wanted to be free'. 'Two years ago, thousands of you came together in a remarkable show of kindness to save a little girl you'd never met,' Ms Mahon wrote on GoFundMe on Saturday. 'Uma Tomarchio, bright-eyed, pony-loving, full of life, was fighting a ferocious battle against cancer. You opened your hearts and gave her the chance to live.' 'They were two miraculous, beautiful, hard-won years. They were her soul's time to play, to love, to teach, and to shine.' When, on May 19, 2025, Uma relapsed for the fourth time, doctors moved quickly, starting treatment and preparing her body for a bone marrow transplant. Just three weeks in, Uma developed a rare and aggressive lung infection that her immune system – weakened by years of therapies – could not overcome. Ms Mahon wrote on the fundraiser she would like to help the family prepare for Uma's farewell. 'While nothing can ease the grief of losing a child, we want to give Uma the beautiful, unforgettable farewell she deserves, and ease the burden on her family, who have endured five years of unimaginable hardship,' she wrote. She is raising funds to cover Uma's outstanding medical costs and a memorial service. Ms Mahon raised the initial $300,000 sum for a life-saving bone marrow transplant for Uma. After successfully receiving the transplant, Uma was declared 'cancer-free' in late October 2022. Until in December, the family learned just before Christmas their little girl had Lymphoma. Uma had 'become unwell at the beginning of December' after receiving the bone marrow transplant just over a month earlier. 'She was admitted to hospital with a fever,' Ms Mahon said. 'Within days she had deteriorated and was sent to ICU with huge amounts of fluid and swollen lymph nodes in her neck.' Uma was put on dialysis as the fluid and toxins were drained from her body, according to Ms Mahon. The family spoke about the ordeal with Carrie Bickmore on Channel Ten's The Project in August 2022. 'She is a very sweet, very happy little girl she always smiles, even in the hospital when she is very sick, she always finds a way to smile,' Ms Gardini told Bickmore. 'One night she was very sick, vomiting and with a temperature and she just looked at me and said ''I'm not flying to the sky mum don't worry, I'm staying with you',' she said 'Even then, in that moment, she was trying to make me feel better.' The Project host, overcome with emotion, struggled to respond - managing a 'wow' as she choked back tears.
The Guardian
13 hours ago
- The Guardian
Harvey Coyne is facing triple-heart bypass surgery. His social housing provider wants to evict him
Sitting on his hospital bed, his voice scratchy and strained, Harvey Coyne gives a bleak insight into what will happen if he's evicted from community housing in Perth. 'Without it, I'm pretty well buggered,' Coyne says. The Noongar elder, 66, is suffering from serious ill health. He has severe heart disease, requiring a pending triple bypass surgery, and this week had another heart attack, which left him hospitalised in Perth's Fiona Stanley hospital. Coyne has emphysema, hypertension and is blind in one eye. Earlier this year, he suffered a fall that left him with a broken hip. He was taken from his family as part of the Stolen Generations, leaving him with complex trauma. Coyne has been forced to fight another battle, too. Sign up for Guardian Australia's breaking news email The provider of his community housing unit in Kenwick, on the south-eastern fringes of Perth, is trying to kick him out. The organisation, Housing Choices Australia, has used a no-fault eviction – something that Western Australia, unlike most other states, still deems lawful – to remove him. Coyne and his advocates say the decision to evict him will force him into homelessness, returning him to the rough sleeping that he endured before moving into the Housing Choices Australia property in 2021. Court documents allege the termination notice was sent while Coyne was both hospitalised and grieving for his nephew, who died while living with him. The documents allege he was subjected to 10 inspections in a single year. Each raised new issues that Coyne said he 'struggled to address … due to my age and health'. The case has led to an intervention by leading health researcher Emeritus Prof Fiona Stanley, a former Australian of the Year and namesake of the hospital where Coyne was being treated this week. Stanley earlier this year wrote to Housing Choices Australia expressing her 'grave' concerns about its treatment of Coyne – particularly given his pending triple-bypass. 'This is an extremely serious operation with a number of risks for Mr Coyne. It is imperative that he has stable and secure accommodation in which to prepare for this procedure and then to recover and rehabilitate afterwards,' Stanley wrote in March. 'Mr Coyne's condition is life-threatening, and it is inconceivable to me that he should face homelessness at this time.' Coyne is now fighting his eviction in the Perth magistrates court, which is due to deliver judgment next week. Housing Choices Australia said it was unable to comment on Coyne's case specifically due to ongoing legal proceedings and privacy concerns. 'Housing Choices Australia is committed to providing safe, secure, and appropriate housing for all our residents and supporting them to sustain their tenancies,' the chief executive officer, David Fisher, said. 'As a not-for-profit community housing provider, we operate under the same standards and regulatory requirements as government housing agencies, and we take that responsibility seriously.' It previously told advocates it was working with the state government to find a 'sustainable housing solution that considers both his immediate and longer-term needs'. Sign up to Breaking News Australia Get the most important news as it breaks after newsletter promotion Court documents suggest it had previously raised concerns about noise, visitation and the cleanliness of the property, all of which Coyne disputes. Academics and Coyne's housing advocate, Jesse Noakes, say his case is symptomatic of a broader issue. Coyne's home would once have been part of the public housing system. Now, the state government has shifted it to community housing under the management of Housing Choices Australia. Experts say state and federal governments are increasingly relying on organisations like Housing Choices Australia to house low-income and vulnerable citizens. The trend is leading to unnecessary evictions and the erosion of tenant rights, they say. In a briefing paper on Coyne's case, David Kelly, a human geographer with RMIT's Centre for Urban Research, said community housing units had increased by 61.4% in the past decade, helped in part by heavy government subsidies. The stock of public housing units had declined by 7.4% over the same period. Kelly said the shift had 'redefined both the nature of the tenancy and the rights attached to it'. 'Tenants like Harvey, had they remained in public housing, would have been afforded stronger on-paper protections against eviction, and subjected to fewer behavioural interventions disguised as support,' he said. 'These homes have been steadily moved into the portfolios of community housing organisations (CHOs), who operate under different regulatory frameworks and priorities.' Housing Choices Australia receives public funding. Records filed with the ACNC suggest about half of its yearly revenue, or roughly $33m, comes from government funding. It also manages a huge number of dwellings. As of mid-2024, records show it owned 3,099 units and managed a further 4,395 units of housing. Its total assets are worth $1.2bn, according to its latest financial reports. The not-for-profit publicly states that its vision is for 'all people in Australia to have a safe, affordable home and the opportunity to thrive'. WA Greens MLC Tim Clifford said Coyne's case illustrated the dangers of outsourcing public housing. He said it was 'unconscionable' that he should face eviction, given his ill health. 'It is clear from Mr Coyne's case that the choice to outsource public housing to big NGOs means that there is less transparency, less accountability and less access to justice for renters,' Clifford said. Fisher said Housing Choices Australia strongly believed that community housing -operated social housing was an important part of the solution to the 'growing housing crisis in our country'.
